Both glial cell line-derived neurotrophic factor (GDNF) and its recently discovered congener, neurturin (NTN), have been shown to excert neuroprotective effects on lesioned nigral dopamine (DA) neurons when administered at the level of the substantia nigra. In the present study, we have explored the relative in vivo potency of these two neurotrophic factors using two alternative routes of administration, into the striatum or the lateral ventricle, which may be more relevant in a clinical setting. In rats subjected to an intrastriatal (IS) 6-hydroxydopamine (6-OHDA) lesion, GDNF and NTN were injected every third day for 3 weeks starting on the day after the 6-OHDA injection. GDNF provided almost complete (90-92%) protection of the lesioned nigral DA neurons after both IS and intracerebroventricular (ICV) administration. NTN, by contrast, was only partially effective after IS injection (72% sparing) and totally ineffective after ICV injection. Although the trophic factor injections protected the nigral neurons from lesion-induced cell death, the level of expression of the phenotypic marker, tyrosine hydroxylase (TH), was markedly reduced in the rescued cell bodies. The extent of 6-OHDA-induced DA denervation in the striatum was unaffected by both types of treatment; consistent with this observation, the high rate of amphetamine-induced turning seen in the lesioned control animals was unaltered by either GDNF or NTN treatment. In the GDNF-treated animals, and to a lesser extent also after IS NTN treatment, prominent axonal sprouting was observed within the globus pallidus, at the level where the lesioned nigrostriatal axons are known to end at the time of onset of the neurotrophic factor treatment. The results show that GDNF is highly effective as a neuroprotective and axon growthstimulating agent in the IS 6-OHDA lesion model after both IS and' ICV administration. The lower efficacy of NTN after IS, and particularly ICV, administration may be explained by the poor solubility and diffusion properties at neutral pH.
Introduction
Glial cell line-derived neurotrophic factor (GDNF) has been shown to exert strong survival-promoting effects on mesencephalic dopamine (DA) neurons both in culture (Lin etal., 1993) and in vivo after mechanical (Beck etal., 1995) or toxic insults (Hoffer etal., 1994; Sauer etal., 1995; Tomac etal., 1995a) . Recently, a second member of the GDNF family, neurturin (NTN)= was cloned on the basis of its survival-promoting actions on sympathetic neurons (Kotzbauer et al., 1996) . NTN, like GDNF, is expressed in the developing and adult nigrostriatal system (Widenfalk et al., 1997; Horger et al, 1998) , and has survival-promoting effects on foetal DA neurons in culture (Horger et al, 1998) . Further, a putative receptor for NTN, the GFRa-2 receptor (Baloh etal., 1997; Buj-Bello etal., 1997; Klein etal., 1997) , has been disclosed and found to signal in a similar way to the GDNF receptor, GFRa-1 (Jing etal., 1996; Treanor etal., 1996) , by formation of a complex with the Ret tyrosine kinase receptor (Trupp et al., 1996) .. In situ hybridization studies indicate that GFRa-2 is Correspondence: C. Rosenblad, as above. E-mail: carl.rosenblad@mphy.lu.se
Received 8 September 1998 , revised 2 December 1998 , accepted 7 December 1998 expressed in the ventral midbrain during development (Klein et al, 1997; Horger etal., 1998) ; nevertheless, the NTN signal appears to be mediated by the GFRa-1 in nigral DA neurons (Cacalano etal., 1998) .
In vivo, both GDNF and NTN have been shown to exert neuroprotective effects on axotomized nigral DA neurons in the intrastriatal (IS) 6-hydroxydoparmne (6-OHDA) lesion model after repeated injections over the substantia nigra (SN) (Sauer etal., 1995; Horger etal., 1998) . Although supranigral injections are effective in protecting the cells within the SN, the dopaminergic innervation of the striatum, which is important for the function in the nigrostriatal system, is not spared (Sauer et al., 1995; Winkler et al., 1996) . However, there are data to indicate .that these neurotrophic factors may act not only on the nigral cell bodies but also at the level of the axonal terminals within the striatum (see Björklund etal., 1997 for review). Thus, GDNF injected into the striatum has been reported to have neuroprotective effects when adrninistered at the time of the 6-OHDA lesion (Shults etal., 1996) and restorative effects when administered after the lesion, either in MPTP-lesioned mice (Tomac et al., 1995a) or in rats subjected to an IS 6-OHDA lesion (Rosenblad etal., 1998) . Consistent with these findings, Tomac et al. (1995b) have observed that GDNF is retrogradely transported to the cell bodies in the SN after injection into the striatum. Striatum, or the adjacent lateral ventricle, may therefore be preferable routes of administration of these factors. From a clinical standpoint, delivery of GDNF into the cerebral ventricles would be attractive as this route is more readily accessible and may allow long-term administration. Lapchak etal. (1997a,b) and have reported that GDNF injected into the cerebrospinal fluid can get access to the nigral DA neurons, and results in increased DA levels and DA turnover in the SN. However, no evaluation of the neuroprotective effects of intracerebroventricular (ICV) treatment was performed in these previous studies.
In the present study we have explored the relative in vivo potency of GDNF and NTN when administered either intrastriatally or intraventricularly in the IS 6-OHDA lesion model.
Materials and methods

Surgical procedures
All work involving animals was conducted according to the rules set by the Ethical Committee for Use of Laboratory Ariimals at Lund University.
A total of 40 young adult female Sprague-Dawley rats (B&K Universal, Stockholm, Sweden) were used and housed under a 12 h lighfcdark cycle with free access to rat chow and water.
Retrograde labelling of the DA neurons from the striatum and IS 6-OHDA lesion were performed under aseptic conditions according to Sauer & Oertel (1994) . Briefly, under Equithesin anaesthesia (0.3 mL/100 g), the rats were injected bilaterally with 0.2 (iL of a 2 % solution (dissolved in 0.9% NaCl) of the retrograde tracer FluoroGold (FG; Fluorochrome, Englewood, CO, USA). Injections were performed using a 2 U.L Hamilton syringe at coordinates: AP, + 1.0 mm; ML, ± 3 . 0 mm relative to bregma; DV, -5.0 mm relative to the dura and incisor bar set to 0.0 mm. The injection rate was 0.05 tiL/min, leaving another 5 min before the needle was retracted.
Seven days after retrograde labelling, the animals were re-anaesthetized, and with a 10 )iL Hamilton syringe a single deposit of 20 (ig 6-OHDA (Sigma-Aldrich, Sweden; calculated as free base and dissolved in 3 uL ice-cold saline supplemented with 0.02% ascorbic acid) was injected into the right striatum in the same location as the FG deposits. The injection rate was 1 uL/min, leaving another 3 min before retracting the needle.
In the same session as the 6-OHDA lesion, two screws were put in the skull bone and a 26-gauge guide cannula (Plastics One, Roanoke, VA, USA), cut to penetrate the bone (0.5-0.7 mm), was placed vertically on the scull surface and fixed with dental cement. The cannulas were implanted at AP, + 1 . 0 mm, ML, 3.0 mm for IS or AP, 0.0 mm, ML, 1.2 mm for intracerebroventricular (ICV) injections, respectively, with incisor bar -3.3 mm.
Neurotrophic factor injections
Every third day for 3 weeks, starting 1 day after the 6-OHDA injection, the rats received an IS (2 u.L/inj) or ICV (4 |iL/inj) injection of NTN (2.5 u.g/uL dissolved in 1 mM HC1; Genentech, South San Francisco, CA, USA), GDNF (2.5 u.g/uL dissolved in 1 mM HC1; Genentech) or vehicle. The injections were performed under halothane anaesthesia using a 33-gauge injection cannula, connected by a piece of plastic tubing to a 10 (iL Hamilton syringe. The injection cannula was cut to protrude 5.0 mm or 3.3 mm into the brain for IS and ICV injections, respectively. The speed of injection was 0.5 uL/min, and 1 min was left before retracting the injection cannula.
Throughout the course of the experiment the weight of the animals was monitored.
The non-specific damage induced by the multiple injections into the striatum was assessed in sections stained for the striatal neuron marker DARPP-32. The size of the lesion, 0.5-0.7 mm wide and 1.2-1.5 mm high, did not differ significandy between the intact and lesioned side, and was similar in the animals that had received IS or ICV injections of vehicle or neurotrophic factor, indicating that this damage was primarily caused by the FG injection.
Drug-induced rotation
At 4 weeks after 6-OHDA lesion, i.e. 1 week after the last intracerebral injection, the rats were injected s.c. with apomorphine (0.25 mg/kg; Apoteksbolaget, Sweden) and monitored for turning response in automated rotometer bowls over 40 min, as described by Ungerstedt & Arbuthnott (1970) . Two days later the animals were injected i.p. with amphetamine (2.5 mg/kg; Apoteksbolaget) and the turning response was monitored similarly over 90 min.
Tissue processing
At 31 days after the 6-OHDA injection (12 days after the last neurotrophic factor injection), the animals were deeply anaesthetized with chloral hydrate and transcardially perfused with saline (pH 7.4; room temperature) for 1 min followed by 200 mL ice-cold formaldehyde solution (4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4). The brains were dissected and postfixed in the same fixative for 3-4 h, and then transferred into 2 5 % sucrose/0.1 M phosphate buffer for 48 h.
Five series of 40-u.m sections through the striatum and SN were cut on a freezing microtome. Tyrosine hydroxylase (TH) immunohistochemistry (THC) and DARPP-32-LHC was performed on serial sections as described previously (Wictorin etal., 1989; Sauer etal., 1995) . Sections processed for immunofluorescence were preincubated in blocking solution [2% normal donkey serum (NDS) + 0.25% Triton X-100 in KPBS] for 1 h at room temperature (RT) and. then incubated for 24-36 h at 4 °C with primary antibody (rabbit-anti-TH; 1:250, Pel-Freez, Rogers, USA) followed by incubation with Cy3 conjugated donkey-antirabbit secondary antibody (1:200 in blocking solution; Jackson, ImmunoResearch Laboratories, West Grove, USA) for 2 h.
For Hu/TH double-immunofluorescence, a second series of sections through the SN was used. Following preincubation in blocking solution [2% NDS + 2% normal horse serum + 0.25% Triton X-100 in KPBS] for 1 h at RT, the sections were incubated with mouseanti-Hu (1:1000; courtesy of Dr Steven A. Goldman) and rabbit-anti-TH (1:250) in blocking solution for 36 h at 4 °C. Subsequently, the sections were incubated for 2 h with Cy3 conjugated donkey-antirabbit IgG (1:200) and biotinylated horse-antimouse (1:200, Vector Laboratories, Burlingame, USA) in blocking solution followed by signal amplification using a tyramide amplification kit (TSA-kit, DuPont, Bad Homburg, Germany) according to the manufacturers instructions and incubation for 2 h with FITC-conjugated avidin.
Quantitative assessment of dopaminergic neurons in the SN
The number of FG-labelled and TH immunoreactive (TH-ir) neurons in the SN pars compacta was assessed by a blinded observer as described previously (Sauer & Oertel, 1994) . In brief, three consecutive sections centred around the level of the medial terminal nucleus of the accessory optic tract (MTN, in the atlas of Paxinos & Watson, 1997) were used, and all labelled/stained neurons laterally to the MTN were counted at 40 X magnification (n = 6-7/group). FG-labeDed neurons were included if they were brightly fluorescent under epi-illumination at 330 nm, displayed a neuronal profile and extend at least one neuritic process. TH-ir neurons (excited at 530 nm) were counted when displaying a nucleus surrounded by TH-ir (red) cytoplasm.
For counting the Hu/TH or FG/TH double-labelled neurons, a level of the SN pars compacta corresponding to the rostral of the three sections used for assessing FG-positive and TH-ir cell number was chosen. At least 100 Hu-positive (30 FG-positive) neurons on the intact side and 50 (25 FG-positive) on the lesioned side were assessed with respect to their TH-immunoreactivity, by alternating between 450 nm (330 nm for FG) and 530 nm excitation filters.
Nigral DA neuron cell size
In three coronal sections corresponding to the levels used for assessment of nigral cell number, the area of the TH-ir neuronal profiles was measured using an Olympus C.A.S.T.-Grid system (Olympus Denmark A/S, Aarhus, Denmark). The SN pars compacta on the ipsi-and contralateral sides were outlined, and a minimum of 90 cells were selected for analysis by random placement of a counting frame which was systematically moved through the delineated area. Neurons were measured if they were sectioned through the nucleus and displayed TH immunoreactivity in the cytoplasm. The measurement was made using the two-dimensional area estimation probe which was placed over the centre of the nucleus.
Density of striatal TH-ir innervation, striatal cross-sectional area and non-specific striatal damage
The optical density of striatal TH-ir innervation and striatal crosssection area were measured in each animal at five different rostrocaudal levels corresponding to + 1 . 6 mm, + 1 . 0 mm, + 0 . 4 mm, -0 . 2 mm and -0 . 8 mm relative to bregma (Paxinos & Watson, 1997) . Images from coronal sections of the ipsi-and contralateral striatum were taken with a high-resolution ProgRes digital camera (Kontron, Germany) from an Olympus microscope equipped with a natural density filter to give constant iUumination throughout the specimen. The digitalized images were analysed using NTH Image 1.60 (Wayne Rasband; NIMH, Bethesda, USA) run on a Macintosh 8500/66 computer. Optical density readings were corrected for background staining (completely denervated 6-OHDA-lesioned striatum). To avoid differences in staining intensity between individual animals, all values are expressed as per cent of the intact contralateral striatum.
Statistical analysis
Analysis of rotational behaviour and body weights was performed using one-way ANOVA and two-way repeated measures ANOVA, respectively; when significant (P < 0.05), comparisons between groups were performed by Newman-Keuls post hoc analysis. For morphological parameters (cell counts, cell size, optical density readings and striatal area), intergroup comparisons was made with one-way factorial ANOVA followed by Scheffe's post hoc analysis. Side differences (lesion versus intact) within groups were analysed using paired Student's r-test.
One animal was excluded from the analysis due to a misplaced 6-OHDA injection.
Results
Sustained administration of neurotrophic factors protects nigral DA neurons from 6-OHDA-induced retrograde degeneration
The neuroprotective effects of GDNF and NTN, administered via either the IS or ICV routes, were compared in the partial 6-OHDA lesion model. Nigral DA neurons were retrogradely labelled with FG from an injection placed in the rostral striatum. One week later, the animals were subjected to a terminal 20 jig 6-OHDA lesion. Starting on the following day, injections of neurotrophic, factors or vehicle were made into the striatum (5 Ug/inj) or the ventricular system (10 Ug/inj), through an indwelling guide cannula, every third day for 3 weeks. The animals were perfused for microscopic analysis 12 days after the last injection.
Retrogradely labelled neurons
After repeated injections into the striatum ( Figs 1A and 2 ), the number of FG-positive neuronal profiles on the lesioned side in the vehicletreated group was markedly reduced to 27.3 ± 3.2% of that on the contralateral intact side (P < 0.01). Closely associated with the reduction in cell number was the appearance of brightly labelled small microglia-like profiles with fine reticular processes in the SN pars compacta (Fig. 4F) . A double-labelling study has previously shown that these cells are microglia that have phagocytosed FG-positive cellular debris (Crews & Wigston, 1990) . In contrast, following repeated IS injections of NTN or GDNF, significantly more FG-positive neuronal profiles remained on the lesioned side (NTN: 72.8 ± 1.9%; GDNF: 92.0 ± 4.4%; P < 0.01 in both cases, Figs 1A and 2E,H). This was accompanied by a conspicuous decrease in the number of FG-labelled microglia. Neuronal sparing was significantly greater in the GDNF-treated animals compared to the NTN-treated animals (JP < 0.01), and indistinguishable from that on the intact contralateral side.
Following ICV injections (Figs IB and 2C), FG-positive nigral cell number in the vehicle-treated groups was reduced to 34 ± 3.0% of that on the contralateral side (P < 0.01). NTN delivered repeatedly into the lateral ventricle (10 Ug/inj) failed to protect the axotomized nigral neurons (P > 0.05), the cell number amounting to 39.1 ± 9.9% of the retrogradely labelled neurons on the contralateral intact side (Figs IB and 2F). By contrast, ICV administration of GDNF at the same dose provided near-complete protection of the FG-labelled neurons on the lesioned side (90.5 ± 9.4%; P < 0.01, Figs IB and 21).
TH-ir nigral neurons and dendritic projections to SN pars reticulata
On the intact side, the SN pars compacta displayed the normal complement of large densely packed TH-ir (immunoreactive) neuronal profiles giving rise to a dense TH-ir innervation of the pars reticulata (Fig. 3A ,D,G). On the 6-OHDA-lesioned side, in the vehicle-treated animals there was a marked reduction in the number of TH-ir neurons accompanied by a loss of TH-ir fibres in the pars reticulata (Fig. 3B,C) . Quantification (Fig. 1C,D) revealed that the number of TH-ir neurons was reduced to 48.5 ± 7 . 1 % and 54.5 ± 5.2% of the contralateral side in the IS and ICV injection groups, respectively. Repeated IS injections of NTN or GDNF resulted in a significant but incomplete protection compared to the vehicle control group (79.9 ± 3.6% and 83.8 ± 4 . 1 % of the contralateral side, respectively; P < 0.05) (Fig. 3H) . Further, similar to what was seen for the retrogradely labelled nigral neurons, ICV injections of GDNF gave a near-complete protection of TH-ir neurons (89.9 ± 3.0%, P < 0.01), while no protective effect was seen with the NTN treatment group (54.3 ± 5.3%, Fig. 3F,I ). In the IS NTN group and in both GDNF groups the TH-ir dendritic projections in the pars reticulata were partially spared: the density of the TH-ir fibres was reduced compared to the contralateral intact side but not to the same extent as in the vehicle-treated animals. In the control groups receiving vehicle alone, there was an = 75% reduction in FG-labelled nigral neurons in both groups (P < 0.01, paired r-test). IS injections of 7 X 5 ug of either GDNF (« = 6) or NTN (n = 6) resulted in a significant protection of the nigral FG-labelled neurons, although the neuroprotective effect was more prominent following GDNF administration (ANOVA with post hoc Scheffe, F 5 i 3 1 = 15.42; P < 0.01). GDNF given into the lateral ventricle (n = 6) (B) gave near-complete protection (90%), whereas NTN (n = 6) administered in this way was ineffective and not different from the vehicle-treated animals. (C,D) In the vehicletreated controls, the number of TH-ir nigral neurons was reduced to 48 ± 7.1% in the IS group (n = 6) and 54 ± 4.3% in the ICV group (n = 7) of that on the intact side. IS injections of NTN (n = 6) or GDNF (n = 6) significantly increased the number to a similar extent, 80 ± 3.6% and 84 ± 4.1%, respectively (ANOVA with post hoc Scheffe, F 5 i 3i = 8.65; P < 0.01). Treatment with GDNF'via the ICV route (n = 6) gave a near-complete protection (90 ± 3.0%), while NTN (n = 6) did not differ from the vehicle-injected control group. #, Significantly different from intact contralateral side; *, different from vehicle-treated group. 
Effects of IS 6-OHDA and trophic factor injections on THimmunoreactivity in the SN
It is known that neurons can respond to injury by downregulating expression of their phenotypic markers. In order to determine to what extent TH was downreguiated by the 6-OHDA lesion and if this was counteracted by administration of either NTN or GDNF, we performed double-labelling of the SN pars compacta neurons with TH and an independent neuron-specific marker, Hu (Barami et ah, 1995) . In coronal midbrain sections, Hu was strongly expressed in neurons throughout the section, including pars compacta and pars reticulata of the nigral complex and the ventral tegmental area. Throughout the microscopic analysis, no single TH-ir neuron was found to be Hunegative, indicating that Hu is a robust independent neuronal marker for the dopaminergic neuronal population in the SN.
The results of the double-labelling experiment are summarized in Table 1 . On the intact non-lesioned side the number of neurons in SN pars compacta that expressed Hu but not T H ( H u + T H -) did not differ significantly between any of the groups (from 3.5 ± 1.0% in the IS vehicle group to 4.6 ± 0.7% in ICV vehicle group). Representative pictures of the extent of colocalization of Hu and T H are shown in Kg. 4G-I. On the lesioned side this percentage was significantly increased in all groups ranging from 9.4 ± 2.8% in the ICV NTN group to 18.0 ± 2 . 1 % in the IS GDNF group (P < 0.01). However, no significant differences were found between the different treatment groups on the lesioned side (P > 0.05; ANOVA).
Estimation of the percentage of F G + T H -c e l l s (Table 1) confirmed toe findings from the Hu/TH double-labelling. On the intact side the percentage was on average 7.8 ± 1.9%, while on the lesioned side the corresponding figure was 13.6 ± 4.0% in animals that did not show any rescue of the nigral neurons (both vehicle groups and the ICV NTN group) and 14.0 ± 3.1% in animals where a protective effect was seen (the IS NTN group and both GDNF groups).
Upon inspection of the perikarya of individual neurons it was noticeable that in animals displaying a protective effect of trophic factor injections (IS NTN and both GDNF treatment groups) the intensity of TH-immunofluorescence on the lesioned side was markedly reduced compared to that of the intact side ( Fig. 4A-D) . Although this reduction was seen in a majority of neurons in the SN pars compacta, neurons with normal TH-ir intensity were mtenningled with the weaker ones (Fig. 4C,D) . In contrast, in animals receiving vehicle injections, the spared nigral neurons did not appear to have a reduced TH-ir (Fig. 4B) .
Lesion-induced atrophy of nigral DA neurons
In order to investigate the long-term effects of IS 6-OHDA, as well as ICV or IS NTN or GDNF, on the size of nigral DA neurons, we measured the cross-sectional area of TH-ir neuronal profiles on the intact and lesioned side. On the intact side the cross-sectional area was 188 ± 6 urn 2 , 192 ± 9 urn 2 and 190 ± 15 urn 2 in the vehicle-, NTN-and GDNF-treated groups, respectively. Following 6-OHDA lesion, the TH-ir profile area of the spared SN neurons was nonsignificantly reduced to 93 ± 9% of the control in the vehicle-treated groups. In NTN-and GDNF-treated animals, the corresponding figures were 102 ± 5 % and 98 ± 3 % , respectively (IS and ICV groups combined). Cell sizes did not differ from each other in the three treatment groups CP > 0.05; ANOVA). , most large neuronal profiles had disappeared and FG was instead seen in small cells with fine reticular fibres resembling phagocytic microglia cells. In the NTN-and GDNF-treated animals (E,H), the picture on the ipsilateral side was similar to that seen on the intact side, with large numbers of rescued FG-labelled cells and few small FG-positive microglia-like cells. ICV treatment: the 6-OHDA lesion resulted in a loss of the majority of FG-positive neurons in the vehicle-treated animals (C). A similar picture was seen following NTN treatment (F), but not in GDNF-treated animals (I) where the number and morphology of the FG-labelled nigral neurons were indistinguishable from the intact side.
FIG. 3. TH-ir neurons in the SN following IS or ICV treatment with vehicle (A-C), NTN (D-F) or GDNF (G-I)
. On the intact side (A,D,G) the SN contained numerous densely packed TH-ir neurons and a dense cienclrilic arbour extending into the pars reticulata. Intrastriatal injections: on the lesioned side, following vehicle treatment (B), a reduction in the number of TH-ir neurons can be appreciated along with a marked reduction of the dendritic projections to the pars reticulata. These changes were partially, but not completely, reversed after NTN or GDNF treatment (E,H). ICV injections: following ICV treatment, both the vehicle and NTN groups displayed a clear lesion-induced reduction in the number of TH-ir neurons and dendrites (C,F), while GDNF treatment protected the nigral cell bodies also with this route of administration (I), m, medial terminal nucleus.
Striatal dopaminergic innervation
TH-IHC performed on sections through the striatum revealed a clear lesion-induced reduction in TH-immunoreactivity that appeared to be similar in extent in all six groups. Representative pictures of the lesioned area, taken from three different rostrocaudal levels through the striatum are shown in Fig. 5 A -C . The lesion area was most prominent in the rostral and lateral striatum, reaching a maximum diameter of 2-2.5 mm, with a less pronounced reduction in the caudal part (Fig. 5C ).
Optical density readings of the TH-ir fibre innervation of the striatum at five evenly spaced rostrocaudal levels (termed 1-5, with 1 being the most rostral) were used to assess the magnitude of striatal denervation in the six different treatment groups. In the vehicletreated animals, the density of the remaining TH-ir innervation on the lesioned side ranged from 30.0 ± 7.7% in section 2 to 46.7 ± 10.2% in section 5 in the IS treatment group, and from 43.3 ± 7.7% in section 3 to 65.6 ± 6.8% in section 5 in the ICV treatment group. The levels of denervation seen in the groups receiving NTN or GDNF did not differ from that seen in the vehicle-injected animals PSTTN: from 24.7 ± 4.0% (section 2) to 48.8 ± 6.6% (section 5), r and from 31.5 ± 6.3% (section 2) to 59.2 ± 9 . 1 % (section 5) in IS and ICV groups, respectively; GDNF: from 20.7 ± 6.2% (2) to 28.6 ± 5.0% (5) in the IS group, and from 29.6 ± 6.4% (2) to 59.2 ± 9 . 1 % (5) in the ICV group].
It has been shown that already by 1 day postlesion, much of the striatal terminal degeneration has already taken place (Jenkins et al., 1993; Kirik et al., unpublished observations) , and that the lesioned axons during the first few days after lesion retract back toward the cell bodies (Rosenblad et al., in preparation) . Therefore, we examined the TH-ir fibres along the nigrostriatal pathway in coronal sections to see if signs of regenerating fibres could be detected outside the striatum. In the globus pallidus (GP) on the intact side (Fig. 6A,B) , thick TH-ir fibres and fibre bundles with few branches coursed dorsolateral^ along the myelinated fibre bundles of the internal capsule to the striatal border, while on the side of the 6-OHDA lesion the GP was devoid of TH-ir fibres, except in the most ventrolateral aspect of the GP-striatal border (Fig. 6D,E) . Also in the neurotrophic l factor-treated animals, the TH-ir axons entering the striatum from the GP were greatly reduced similarly to what was seen in the vehicleinjected groups. However, centrally in the GP a marked increase in TH-ir staining was seen in animals from the two GDNF-treated and the IS NTN-treated groups (i.e. in the groups where a marked neuroprotective effect of trophic factor administration was seen, Fig. 6F ). This area of increased TH-ir contained a high density of thin, irregular fibres with many varicosities, resembling regenerating fibres (Fig. 6G) . In animals that had received GDNF or NTN intrastriatally, the areas of newly formed fibres were located centrally in the GP, caudal to the injection site, whereas in the ICV-injected animals this area occurred more medially, close to the lateral ventricle.
Measurement of the striatal cross-sectional area at the five different rostrocaudal levels (performed to determine any shrinkage due to the 6-OHDA lesion) did not reveal any significant difference between the intact side (with an average area of 6.2-9.3 m m 2 depending on rostrocaudal level) and the lesioned side (100.3 ± 2.0-110.4 ± 3.6% of intact side at the same rostrocaudal level).
Drug-induced rotation
At 4 weeks postlesion, the animals received a single injection of amphetamine (2.5 mg/kg i.p.) which elicited an ipsilateral turning response in all groups ( Table 2 ). The groups receiving ICV injections of vehicle, NTN or GDNF did not differ significantly from each other (8.0 ± 3.3, 12.0 ± 2.1 and 12.7 ± 1.7 tams/min, respectively; P > 0.05). Similarly, the IS treatment groups did not differ in their tuming response (6.6 ± 3.4, 10.5 ± 3.1 and 5.9 ± 1.9 tums/rnin for the vehicle, NTN and GDNF groups, respectively; P > 0.05).
Subcutaneous injection of apomorphine (0.25 mg/kg, Table 2 ) did not elicit any significant rotational asymmetry (average between 0.5 and 2.2 contralateral tums/rnin for the different treatment groups). However, the extent of striatal denervation caused by this lesion has previously been reported to be insufficient to induce a significant 9.4 ± 2.8* -13.6 ± 4.0 f ± 0.9 14.7 ± 2.3* -12.4 ± 5.2 ± 1 . 0 .12.4 ± 2 . 6 * -13.6±4.0 f ± 0.6 14.9 ± 0.8* -8.2 ± 1.9 ± 1.3 18.0 ± 2.1* -20.3 ± 6.3 7.8 ± 1.9 *P < 0.05 (paired Mest) compared with the intact side. The different treatment groups did not differ significantly from each other ( F 5 2 5 = 2.33 and ^5,25 = 1-03, ANOVA, for Hu + TH~ and FG + TH", respectively, P > 0.05). f In these three groups, the results were pooled and the the mean ± SEM from all three groups are shown, because of the low number of residual cells on the lesioned side.
FIG. 4. (A-D)
Confocal microscopy images of TH-stained sections through SN. The pictures were processed in parallel with exacdy the same settings to illustrate the marked reduction in the intensity of TH-ir of many of the rescued neurons following NTN or GDNF treatment (arrowheads in C,D), compared to either the intact side (A) or the spared neurons on the lesioned side in vehicle-treated animals 03). Although the intensity of labelling is reduced, the neuronal profiles have a normal morphological appearance and only a small reduction in TH-ir cell number could be detected (see Figs 1 and 3) . (E,F) High-power magnifications of a retrogradely labelled 'healthy' neuron (E) and a microglia-like small cell (F) with a non-neuronal shape and fine short processes, respectively. The latter most likely represents phagocytic cells that have accumulated FG-labelled debris from dead neurons and which appear in the SN following 6-OHDA-induced cell death (cf. Crews & Wigston, 1990) . (G,H,I ) Pseudo-coloured images from the intact SN pars compacta colabelled for Hu (green; C) and TH (red; D). When combining the two (T) there is an almost complete overlap of the two markers. The arrow indicates one Hu-positive neuron that does not express TH. apomorphine-induced turning response Rosenblad era/., 1998) 
Body weight
Animals were weighed on the day of the lesion and then weekly throughout the experiment. All groups displayed a significant increase in weight (P < 0.001) and there was no difference between the groups with the same route of administration (i.e. ICV or IS) at any of the time points, indicating that the neurotrophic factors were well tolerated by the animals. Comparison of the two administration routes revealed that animals subjected to ICV delivery weighed significantly less on weeks 1-4 postlesion (-4.2%, -9 . 3 % , -1 3 . 8 % and -4 . 9 % , respectively) than those receiving intraparenchymal injections (P < 0.01 at all time points).
Discussion
The IS 6-OHDA lesion employed here results in a partial progressive loss-of the nigral DA neurons in the SN with an onset at about 1 week postlesion, followed by a gradual decrease in cell number over several weeks or months (Sauer & Oertel, 1994) . The nigral cell death is preceded by a degeneration of the dopaminergic terminals in the striatum which starts to appear within the first day of the 6-OHDA injection and then develops over the following days (Jenkins et al., 1993) . In the present study, trophic factor administration was started 1 day postlesion, i.e. when the acute axonal degeneration is ongoing but before the onset of neuronal cell loss in the SN. The results show that repeated injections of GDNF into either the striatum or ICV over 3 weeks following the 6-OHDA lesion can afford nearly complete protection of retrogradely labelled and TH-ir neurons in the SN pars compacta. NTN injected in the same dose (5 Ug/inj) into the striatum had a similar, though partial, neuroprotective effect. ICV injections of NTN, by contrast, did not afford any protection in this model. These observations support the findings from a previous study, using the same lesion model, where sustained supranigral administration of NTN resulted in complete protection of the nigral DA neurons (Horger etai, 1998) . In the TH-ir neuron cell counts, the extent of protection was similar for both NTN and GDNF after IS administration (80-85%). However, in the FG-labelled cell counts, which more closely reflect the rescue of the axotomized neuron population, the percentage of neurons rescued by the IS NTN treatment (72%) was less than after administration of GDNF (92%), and also less than that seen after supranigral injections of similar doses of factor (Sauer et al, 1995; Horger et al., 1998) . There are at least two alternative explanations for this discrepancy.
One is that NTN diffuses less well in the brain after injection compared to either GDNF or (more importantly) 6-OHDA. This would result in a 'penumbra' zone of lesioned striatum to which the injected NTN protein does not reach and thus the resulting protection is incomplete. As the volume occupied by the SN is smaller than the striatum, NTN injected above the SN could still reach most or all of the lesioned DA neurons and therefore be sufficient to provide complete protection. Differences in solubility and/or diffusion properties between NTN and GDNF could also explain why no protection was seen after ICV injections of NTN (39%) while GDNF was again highly effective. In fact, the NTN fusion protein employed in the present study has been demonstrated to exhibit poor solubility in PlG-6. Administration of GDNF or NTN can induce regeneration from lesioned dopaminergic axons residing in the GR Low-power (A,D,F) and high-power phase contrast photomicrographs from the central GP (indicated by boxed area in A) (B,E,G) of TH-stained sections through the GP. On the intact side (A3), thick TH-ir fibres and fibre bundles with few branches coarsed dorsolaterally through the GP up into the striatum (STR), whereas the same region on the 6-OHDA-lesioned side (D,E) was devoid of TH-ir fibres. By contrast, following IS or ICV GDNF, or IS NTN treatment, a marked TH-IR area (F) was seen in the GP. This contained a dense network of thin, varicose TH-ir fibres with the appearance of regenerating nerve fibres (G). (C) Schematic illustration of the effect of GDNF or NTN treatment started 1 day after an IS 6-OHDA lesion. The axon terminals are rapidly retracted from the part of the striatum surrounding the 6-OHDA injection (empty area), whereas the most medially and caudal areas are relatively spared (hatched areas). By 1 day postlesion, the DA fibres are round caudally in the GP, and GDNF (or NTN) treatment commenced at this point reaches the axonal stumps by diffusion and prevents further retraction of the "ores and induces sprouting from the stumps in the GP. The GDNF also prevents death of the nigral neurons, although the expression of TH is reduced in the spared neurons (light grey neurons projecting to the lesioned area). STR, striatum; GP, globus pallidus; mfb, medial forebrain bundle; SN, substantia nigra; 6-U HDA, 6-hydroxydopamine; veh, vehicle. 12.7 ± 1.7 -2 . 3 ± 1.6 6.6 ± 3.4 -1 . 1 ± 0.5 10.5 ± 3.1 -0 . 5 ± 0.1 5.9 ± 1.9 -0 . 2 ± 0.1
The amphetamine and apomorphine tests were performed on days 3 1 and 2 8 , respectively, after the 6-OHDA lesion. Group comparison did not reveal any significant difference (ANOVA, F 5 I 3 1 = 0.91 and 0.96 for amphetamine and apomorphine, respectively, P > 0.05). Negative values denote turns contralateral to the lesion. neutral pH solutions including monkey or rat cerebrospinal fluid (CSF, Week et al., unpublished observations).
Alternatively, it is possible that N T N and GDNF may not be equipotent in binding and activation of the GFRcx-l/Ret receptor complex. In a recent study in G F R a -1 knockout mice, it has been shown that the survival-promoting effect of NTN on foetal dopaminergic neurons in vitro is abolished in cells lacking the G F R a -1 receptor, and that the responsiveness could be restored after addition of soluble GFRa-1 (Cacalano et al., 1998) . This indicates that NTN in midbrain DA neurons in fact signals through the GFRa-l/Ret receptor complex. However, direct dose-response experiments by injection of equal amounts of NTN or GDNF in a single injection over the SN spares TH-ir and retrogradely labelled nigral neurons to the same extent, indicating that at the doses used here the two factors may be equally effective in vivo when administered directly at the cell body level.
In the present study, repeated ICV injections of GDNF (10 pig every third day) resulted in near-complete protection (90% of F G + and 82% of T H + neurons) of the nigral cell bodies, indicating that dopaminergic neurons can get access to sufficient amounts of the protein from the CSF. This finding is interesting from a clinical perspective as the ICV administration route would be more readily accessible. Injection of radioactively labelled GDNF into the lateral ventricle has been reported to show some limited diffusion into the striatum and SN (Lapchak et al., 1997a) . In support of this notion, increased striatal and nigral DA levels and reduced apomorphineinduced mrning have been observed in 6-OHDA-lesioned rats receiving GDNF intraventricularly (Lapchak etal., 1997b) . Whether these effects are mediated by a direct action of GDNF onto the nigral cell bodies, or if GDNF is able to diffuse in sufficient concentrations into the striatal parenchyma to be taken up by DA axons and terminals in the striatum is, however, not known.
Regulation of TH levels in 6-OHDA-lesioned and rescued nigral neurons
Downregulation of phenotypic markers in response to an axotomizing lesion has been reported for several different neuronal systems, including the nigrostriatal DA system (Keams & Gash, 1995; Bowenkamp etal, 1996; Lu & Hagg, 1997) . We show here, by means of double-labelling with TH antibody and either Hu antibody or FG, that a small portion of the neurons in the SN pars compacta on both the intact and lesioned side does not express detectable levels of TH. The Hu + T H -or F G + T H -neurons on the intact side are likely to represent the subgroup of the nigrostriatal projection neurons that are non-dopaminergic. This subgroup has previously been reported to amount to = 4 % of all neurons in the pars compacta (Guyenet & Crane, 1981) , which compares well with the findings in the present study where an average of 4.6% of the pars compacta neurons on the intact side were Hu + T H -and 7.5% were FG + T H -.
On the lesioned side, the number of Hu + T H -neurons was increased to 12-18% in the different treatment groups. Part of this increase can be attributed to the fact that the number of nondoparninergic nigrostriatal neurons (which are likely to be unaffected by the lesion) would remain constant, and thus increase from 4 to 5% in the intact SN to about 8-10% of the total remaining population following a lesion where the nigral D A cell number is reduced by 50%. Another 5-10% of the spared nigral DA neurons may have downregulated TH in response to the 6-OHDA lesion. Quantitatively, this Hu + T H -neuron population did not change significantly following NTN or GDNF treatment. However, we observed a clear reduction in intensity of TH staining in the cell bodies on the lesioned side in animals displaying good protection following neurotrophic factor injections. This reduced TH expression was not present in control vehicle animals and was not homogenous among the nigral TH-ir neurons, mdicating that the trophic factor treatment did not counteract the lesion-induced downregulation of phenotypic expression in those axotomized neurons that had been rescued by either GDNF or NTN treatment. Conversely, neurons that were spared by the 6-OHDA lesion (i.e. surviving neurons on the lesioned side in control animals and = 60% of TH-ir neurons in the IS NTN and both GDNF groups) displayed normal TH-ir intensity. Our findings are in keeping with the study by Lu & Hagg (1997) where continuous infusion of GDNF (3 u.g/day) over the SN failed to counteract the 6-OHDA lesioninduced downregulation of TH in rescued retrogradely labelled nigral neurons. This study also reported that GDNF alone reduces TH levels in intact nigral neurons (i.e. in the absence of any axotomizing lesion). Although we cannot rule out such an effect, the presence of neurons with normal TH staining intensity in our study suggests that the trophic factors themselves did not suppress TH expression in the undamaged neurons. In another study employing the IS 6-OHDA lesion model, Kearns & Gash (1995) reported that only « 60% of the surviving nigral neurons were TH-ir following a single supranigral GDNF injection. The results from these experiments are in contrast to others reporting increased TH-ir, TH activity and levels of DA following a single injection of high doses of GDNF (Bowenkamp etal, 1995; Gash etal., 1996; Lapchak etal., 1997b) . This discrepancy may indicate that TH levels in lesioned nigral neurons are differentially affected by a prolonged delivery of trophic factor at lower doses and a bolus injection of large amounts of trophic factor.
In contrast to previous reports using the same lesion model (Sauer etal., 1995; Lee etal., 1996; Winkler etal, 1996) reporting a 20-30% reduction in DA neuron cell size, we found only a limited nonsignificant'shrinkage of the nigral TH-ir neurons (93% of the average size on the intact side) following the 6-OHDA lesion. However, in these previous studies, an unbiased random sampling was not used in the quantitative procedure which may have resulted in an overrepresentation of smaller neuronal profiles on the lesioned side.
Striatal dopaminergic innervation and drug-induced rotational asymmetry
In the present study we did not find any signs of protection or regeneration of the TH-ir striatal innervation in the lesioned striatum © 1999 European Neuroscience Association, European Journal of Neuroscience, 11, 1554-1566 TABLE 2. Number of net full body turns per minute following administration of amphetamine or apomorphine by the trophic factor treatment, as measured by optical density of TH-ir fibres. In keeping with the absence of changes in striatal DA innervation, the high rate of amphetamine-induced rotation was unaffected by administration of the neurotrophic factors. This supports the findings by Winkler etal. (1996) where no improvement in amphetamine-induced turning or forelimb akinesia tests was seen following repeated supranigral GDNF injections which spared the nigral cell bodies but not their nigrostriatal axons. It should be noted, however, that although a sensitive indicator of striatal DA depletion, amphetamine-induced rotation correlates poorly with the degree of striatal denervation and performance in spontaneous motor tests (Kirik etal, 1998; Lee etal, 1996) , and does therefore not rule out that behavioural changes may be observed in other tests.
It has previously been shown that GDNF injected IS or ICV can protect striatal DA uptake sites and DA levels when administration is started before the 6-OHDA-induced insult (Opacka-Juffrey et al, 1995; Shults etal, 1996; Sullivan etal, 1998) . In the present experiment, NTN and GDNF treatment was commenced 1 day postlesion, i.e. at a time point when the acute toxin-induced damage to the DA terminals had already taken place. Because much of the terminal degeneration (measured as a reduction in the number of striatal DA uptake sites and TH-ir fibres) occurs during the first 24 h after toxin injection (Jenkins et al, 1993; Kirik et al, unpublished observations) , the neurotrophic factor would have to be administered prior to or at the time of the lesion in order to prevent 6-OHDA-induced damage to the DA terminals in the striatum.
In the present experiment, the IS GDNF and NTN treatment did not induce any measurable sprouting or regrowth of DA axon terminals within the lesioned striatum. By contrast, we observed here prominent axonal sprouting within the GP, most extensively in the animals receiving GDNF injections (either in the striatum or ICV) and to a lesser extent also after IS NTN. This sprouting occurred in the medial aspect of the pallidum (i.e. closer to the lateral ventricle) in the animals receiving ICV injections, and in the central parts (i.e. caudal to the injection site) in the IS injected animals. The distribution of this newly formed axonal network coincides well with the position of the distal stumps of the 6-OHDA-lesioned TH-ir nigrostriatal axons at the time (1 day after the lesion) when the neurotrophic factor treatment was initiated. During the first few days after the 6-OHDA lesion, there is a gradual die-back, or retraction, of the lesioned nigrostriatal axons, and at 1 day postlesion this has progressed = 1 -1.5 mm caudal to the lesion, i.e. up to the level of the caudal GP (Rosenblad et al, in preparation) . This suggests that GDNF injected either IS or ICV can reach the surviving axons within the GP, and not only support the survival and prevent further retraction of the lesioned axons, but also stimulate regenerative sprouting locally at their site of termination. These sprouting axons did not, however, reach into the striatum (a distance of = 0.5-1.0 mm).
The lack of any measurable sprouting response within the lesioned striatum is at variance with the results of a previous study (Rosenblad etal, 1998) where we observed a significant increase in DA uptake sites (as assessed by 3 H-BTCP binding autoradiography) after IS GDNF administration starting 1 month postlesion. However, higher doses of GDNF were used in that study (a total of 50 ug) compared with a total of 35 ug in the present experiment. Based on the present findings, we propose therefore that the initiation of a sprouting response from spared, intact axons within the striatum is observed °nly with tissue levels of neurotrophic factor that are considerably higher than those required to stimulate regeneration, and promote survival, of lesioned dopaminergic axons. Efficient restoration of striatal DA innervation, which is likely to be necessary for optimal functional recovery in the 6-OHDA lesion model, may thus be possible to achieve only with a treatment regimen that involves high doses of GDNF and is initiated early, at the time when the distal stumps of the lesioned nigrostriatal axons still remain within the striatum, so as to allow for both axonal regeneration and sprouting from intact neurons. The conditions under which this may be obtained will have to be clarified in future studies.
Conclusions
This is the first study to compare the neuroprotective effects of sustained IS or ICV administration of NTN or GDNF on nigral DA neurons in the IS 6-OHDA lesion model of Parkinson's disease (PD). This lesion model, which results in a partial progressive loss of nigral DA neurons over several weeks, is likely to better resemble the nigrostriatal pathology seen in patients with PD than the complete unilateral lesion that follows upon 6-OHDA injection into the medial forebrain bundle.
-The results show that GDNF is equally potent when administered into the striatum or ICV as when injected over the SN, as observed previously (Sauer etal, 1995; Winkler etal., 1996; Lu & Hagg, 1997) , while NTN was effective only after IS injection, and no significant neuroprotection was obtained following ICV administration. Together with previous findings (Horger etal, 1998) , these results indicate that NTN as a neuroprotective agent for nigral DA neurons has similar potency as GDNF at the SN level, but is clearly less efficient when administered into the striatum. The poor solubility of the NTN protein at neutral pH may explain why NTN is inefficient from the ICV route. This is the first study to report that nigral D A neurons undergoing progressive neurodegeneration can be rescued by sustained GDNF delivery to the lateral ventricle, and that GDNF adrmnistration by this route can induce a prominent regenerative response from damaged nigrostriatal axons. Previous studies using ICV injections of GDNF in rats with 6-OHDA lesion of the medial forebrain bundle (Lapchak etal, 1997b) and MPTP-treated monkeys (Gash etal, 1996) have reported increases in DA levels and DA metabolism in animals with long-term manifest lesions. This indicates that intraventricular GDNF in addition to its neuroprotective and regenerative effects, may be able to stimulate DA turnover in spared nigral neurons. These data are of particular interest when considering administration of neurotrophic factors to patients suffering from progressive nigral neurodegeneration in early stages of PD, as the ICV route allows more long-term trophic support, either as monotherapy or in combination with transplants of foetal dopaminergic neurons.
